A 50-year-old man with deteriorating cognitive function and impaired movement

PLoS Medicine

Volumn 6, Issue 1, 2009, Pages 0035-0038

  Larner, Andrew J ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; MAPT PROTEIN, HUMAN; TAU PROTEIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FAMILY HISTORY; GENE MUTATION; HUMAN; MALE; MEMORY DISORDER; MENTAL DETERIORATION; MOTOR DYSFUNCTION; ONSET AGE; CHROMOSOME 17; DEGENERATIVE DISEASE; GENETICS; MIDDLE AGED; MUTATION; PARKINSONISM; PROGRESSIVE SUPRANUCLEAR PALSY;

ALZHEIMER DISEASE; CHROMOSOMES, HUMAN, PAIR 17; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; MUTATION; NEURODEGENERATIVE DISEASES; PARKINSONIAN DISORDERS; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 59249097071     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000019     Document Type: Article

References (23)

1. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders. 4th edition, text revision (DSM-IV-TR). Washington (D. C.): American Psychiatric Association. 943 p.
2. Doran M (1997) Diagnosis of presenile dementia. Br J Hosp Med 58: 105-110.
3. Mendez MF (2006) The accurate diagnosis of early-onset dementia. Int J Psychiatry Med 36: 401-412.
4. Ratnavalli E, Brayne C, Dawson K, Hodges JR (2002) The prevalence of frontotemporal dementia. Neurology 58: 1615-1621.
5. Hodges JR, editor (2007) Frontotemporal dementia syndromes. Cambridge (UK): Cambridge University Press. 346 p.
6. Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DM, et al. (1999) Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 66: 184-188.
7. Larner AJ (2008) Neuropsychological neurology: The neurocognitive impairments of neurological disorders. Cambridge (UK): Cambridge University Press. 248 p.
8. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task forces on Alzheimer's disease. Neurology 34: 939-944.
9. Cruts M, van Duijn CM, Backhovens H, Van den Broeck M, Wehnert A, et al. (1998) Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 7: 43-51.
10. Gauthier S, Emre M, Farlow MR, Bullock R, Grossberg GT, et al. (2003) Strategies for continued successful treatment of Alzheimer's disease: Switching cholinesterase inhibitors. Curr Med Res Opin 19: 707-714.
11. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, et al. (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 47: 1-9.
12. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, et al. (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Ann Neurol 41: 706-715.
13. Johns Hopkins University (2008) Online Mendelian inheritance in man. Available: http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim. Accessed 15 December 2008.
14. Bak TH, Hodges JR (1998) The neuropsychology of progressive supranuclear palsy. Neurocase 4: 89-98.
15. Tsuboi Y, Josephs KA, Cookson N, Dickson DW (2003) APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy. Neurology 60: 240-245.
16. Urasaki K, Kuriki K, Namerikawa M, Satoh S, Ikeguchi K, et al. (2000) An autopsy case of Alzheimer's disease with a progressive supranuclear palsy overlap. Neuropathology 20: 233-238.
17. Kasahata N, Arai N, Makita Y (2008) An Alzheimer disease with dementia with Lewy bodies patient presenting progressive supranuclear palsy-like clinical manifestations and radiological atrophy of midbrain tegmentum. A clinical and neuropathological study. J Neurol 255 (Suppl 2): 196.
18. Boeve BF, Dickson D, Duffy J, Bartleson J, Trenerry M, et al. (2003) Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. Eur Neurol 49: 72-78.
19. Mochizuki A, Ueda Y, Komatsuzaki Y, Tsuchiya K, Arai T, et al. (2003) Progressive supranuclear palsy presenting with primary progressive aphasia - Clinicopathological report of an autopsy case. Acta Neuropathol 105: 610-614.
20. University of Antwerp Molecular Genetics Department (2008) Alzheimer disease and frontotemporal dementia mutation database. Available: http://www.molgen.ua.ac.be/Admutations/. Accessed 15 December 2008.
21. Doran M, du Plessis DG, Ghadiali EJ, Mann DMA, Pickering-Brown S, et al. (2007) Familial early-onset dementia with tau intron 10 +16 mutation with clinical features similar to those of Alzheimer disease. Arch Neurol 64: 1535-1539.
22. Larner AJ (2008) Mutation negative "early-onset familial Alzheimer's disease": Consider screening for tau gene mutations. Alzheimer Dis Assoc Disord 22: 194-195.
23. Morris HR, Osaki Y, Holton J, Lees AJ, Wood NW, et al. (2003) Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP. Neurology 61: 102-104.